C
Cellectar Biosciences (CLRB)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Cellectar Biosciences (CLRB)
Cellectar Biosciences, Inc. is a late-stage clinical biopharmaceutical company. The Company is focused on the discovery, development and commercialization of drugs for the treatment of cancer. The Company, through phospholipid ether drug conjugate (P... Read more
- USD0.39
- USD0.40
- USD0.36
- USD3.42
- 53.40%
- --
- 6.40M
- 37.70M
- 12M
- 0.22
- -86.90%
Stock News
1 hour ago
What’s behind Trump’s call for ‘a full point’ interest-rate cut?
MarketWatch
2 hours ago
Guess & G-III earnings, space stocks blast off: Trending Tickers
Yahoo
2 hours ago
Want to know how much jobs matter to the market? Just look at Friday's rally
CNBC
2 hours ago
Cramer says Broadcom is a buy for new investors, Apple stock's less 'treacherous'
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
